We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.69%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.59%
AUM
$3.05B
AUM Growth
-$542M
Cap. Flow
-$855M
Cap. Flow %
-28%
Top 10 Hldgs %
68.02%
Holding
472
New
104
Increased
41
Reduced
44
Closed
200

Top Buys

1
VRNA
Verona Pharma
VRNA
+$447M
2
CYBR
CyberArk
CYBR
+$424M
3
IPG
Interpublic Group of Companies
IPG
+$96.3M
4
COOP
Mr. Cooper
COOP
+$67.2M
5
AL
Air Lease Corp
AL
+$48.8M

Top Sells

1
WBA
Walgreens Boots Alliance
WBA
+$288M
2
SKX
Skechers
SKX
+$227M
3
BPMC
Blueprint Medicines
BPMC
+$220M
4
CHX
ChampionX
CHX
+$187M
5
ANSS
Ansys
ANSS
+$173M

Sector Composition

1 Technology 23.63%
2 Healthcare 16.98%
3 Communication Services 12.23%
4 Financials 11.14%
5 Consumer Staples 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ET icon
251
CALL
Energy Transfer Partners
ET
$70B
$9K ﹤0.01%
600,000
+280,000
+88% +$4.91M
SKT icon
252
PUT
Tanger
SKT
$4.81B
$7.76K ﹤0.01%
+13,500
New +$440K
SCAGW
253
Scage Future Warrants
SCAGW
$6.39K ﹤0.01%
+127,590
New +$7.34K
BRLSW icon
254
Borealis Foods Inc Warrant
BRLSW
$1.07M
$5.36K ﹤0.01%
70,030
– –
MSAIW icon
255
MultiSensor AI Holdings Warrant
MSAIW
$4.88K ﹤0.01%
142,585
– –
BSLKW
256
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$4.41K ﹤0.01%
110,914
– –
RDZNW icon
257
Roadzen Inc Warrants
RDZNW
$6.25M
$4.21K ﹤0.01%
65,696
– –
FE icon
258
PUT
FirstEnergy
FE
$28.5B
$3.25K ﹤0.01%
26,000
– –
OPTXW icon
259
Syntec Optics Holdings Warrant
OPTXW
$16.8M
$2.78K ﹤0.01%
32,034
– –
BNAIW
260
Brand Engagement Network Warrant
BNAIW
$2.67M
$2.42K ﹤0.01%
150,251
– –
AAPL icon
261
CALL
Apple
AAPL
$4.88T
– –
-74,000
Closed -$279K
ABBV icon
262
AbbVie
ABBV
$455B
– –
-13,297
Closed -$2.47M
ACAD icon
263
Acadia Pharmaceuticals
ACAD
$4.36B
– –
-43,000
Closed -$928K
ADPT icon
264
Adaptive Biotechnologies
ADPT
$3.61B
– –
-73,441
Closed -$856K
AGIO icon
265
Agios Pharmaceuticals
AGIO
$2.35B
– –
-56,810
Closed -$1.89M
ALC icon
266
Alcon
ALC
$34.3B
– –
-25,555
Closed -$2.26M
ALGN icon
267
Align Technology
ALGN
$12.6B
– –
-12,755
Closed -$2.41M
ALKS icon
268
PUT
Alkermes
ALKS
$8.66B
– –
-25,000
Closed -$58.1K
AMAT icon
269
Applied Materials
AMAT
$425B
– –
-30,000
Closed -$5.49M
AMD icon
270
Advanced Micro Devices
AMD
$799B
– –
-54,921
Closed -$7.79M
AME icon
271
Ametek
AME
$54.3B
– –
-6,085
Closed -$1.1M
AMED
272
DELISTED
Amedisys
AMED
– –
-474,162
Closed -$46.7M
AMZN icon
273
Amazon
AMZN
$2.68T
– –
-43,190
Closed -$9.48M
ANAB icon
274
AnaptysBio
ANAB
$1.69B
– –
-38,528
Closed -$855K
ANNX icon
275
Annexon
ANNX
$972M
– –
-492,698
Closed -$1.18M
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RCM
RNC Capital Management Los Angeles, California $2.2B AUM 22.93% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

UBS O'Connor's Q3 2025 Portfolio in Review

As of Q3 2025, UBS O'Connor held 472 positions worth $3.05B, down 15% from $3.6B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

UBS O'Connor withdrew a net $855M in Q3 2025, closing 200 positions and reducing 44 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $288M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 15% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, UBS O'Connor opened a new position in Verona Pharma worth $457M.

  • UBS O'Connor's largest Q3 2025 buy was Verona Pharma: 4,283,462 shares worth $457M.
  • UBS O'Connor added most to Interpublic Group of Companies in Q3 2025, an estimated $96.3M increase.
  • UBS O'Connor's biggest Q3 2025 reduction was Kellanova, cutting an estimated $110M.
  • UBS O'Connor fully exited Walgreens Boots Alliance in Q3 2025, selling an estimated $288M.
  • UBS O'Connor's ten largest holdings make up 68% of its $3.05B portfolio in Q3 2025.
  • UBS O'Connor opened 104 new positions and closed 200 in Q3 2025.
  • UBS O'Connor's portfolio value fell 15% quarter-over-quarter to $3.05B.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.